Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Neurologists(?)

Council Members in this Study Group: 1815

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.Daniel Wynn, MD
Director, Clinical Research
Consultants In Neurology Ltd.

Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...

Walter Carlini, MD, PhD
Neurologist
Medford Neurological Clinic, Inc.

Walter Carlini, MD, PhD, is a General Neurologist at Medford Neurological Clinic in Oregon. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis. Dr. Carlini has expertise in clinical neurophysiology and in the use of botulinum toxin injections...

Josef Parvizi, MD, Attending Neurologist, Stanford University Medical CenterJosef Parvizi, MD
Attending Neurologist
Stanford University Medical Center

Josef Parvizi, MD, PhD, is an Assistant Professor of Neurological Sciences at Stanford University. Dr. Parvizi has main interest in analyzing the design and results of new clinical trials, of medications or devices, in various fields of neurology. He has clinical expertise in Alzheimer's disease, neuropathic...

Stephen Landy, MD
Director of Neurology
Wesley Headache Clinic

Stephen Landy, MD, is the Director of Neurology at Wesley Headache Clinic and Clinical Professor in Department of Neurology at University of Tennessee. Dr. Landy is certified by the National Board of Medical Examiners, the American Board of Psychiatry and Neurolgy. Also, he is certified by the National...

Peter Rieckmann, MD
Professor of Neurology and MS Research Chair
UNIVERSITY OF BRITISH COLUMBIA

Peter Rieckmann, MD, FRCPC, is the Chair of Multiple Sclerosis Research and Director of the Multiple Sclerosis Program at University of British Columbia, Canada, and holds a position as Professor of Neurology and Research Group Leader for Multiple Sclerosis and Neuroimmunology at University of Wuerzburg,...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Psychotherapy may save money | 09-11-2008
Author: GLG Expert Contributor

Unfortunately, many insurance payors do not realize that allowing psychotherapy visits may save the money in the long run by reducing the need for much more costly Inpatient psychiatric treatment. I find that my patients who receive psychotherapy are much less likely to miss work and much...

Azilect | 09-02-2008
Author: GLG Expert Contributor

This is a well conceived study and totally convincing

The Devil Is in the Details | 09-01-2008
Author: GLG Expert Contributor

This large study shows that PD patients' severity of motor dysfunction is better on rasagiline than on placebo.

Concerns about the Rember Phase 2 data | 08-06-2008
Author: GLG Expert Contributor

While the clinical trial data remain unpublished, those who attended the ICAD conference remain concerned about the possibility that the effects are not as pronounced as the interpretation by the investigators.

Arm Chair Analysis from Monday Morning Quarterbacks provides unrealistic expectations and inappropriate rules | 06-26-2008
Author: GLG Expert Contributor

Medications used for realistic indications and with clinically appropriate symptomatic targets are indicated and provide effectiveness that additional staff cannot offer.  Decision making in health care is too often made by those who do not really provide clinical service but provide arm chair...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Academic Institution*
  • Non-Academic Community Hospital or Clinic
  • Government/Military Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Professor
  • Director
  • Owner
  • Physician - Department Chair

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-10-07T13:45:18.680